NTRK1 and anaplastic large cell lymphoma: Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor that was first described in 1994 with the characterization of a frequently occurring translocation within a subset of patients with anaplastic large-cell lymphoma (ALCL) [1].